Triple Antibiotic
- Manufacturer
- E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | Fougera Pharmaceuticals Inc.
- Effective date
- 2012-10-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:44:48
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredients (in each gram)
- Neomycin Sulfate (5 mg equivalent to 3.5 mg neomycin base)
- Polymyxin B Sulfate (equal to 5,000 polymyxin B units)
- Bacitracin Zinc (equal to 400 bacitracin units)
Purpose
Antibiotic
Antibiotic
Antibiotic
Uses
first aid to help prevent infection in
- minor cuts
- scrapes
- burns
For external use only
OTC - DO NOT USE SECTION
Do not use
- in the eyes
- over large areas of the body
- if you are allergic to any of the ingredients
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor before use in case of deep or puncture wounds, animal bites or serous burns
OTC - WHEN USING SECTION
When using this product do not use longer than 1 week unless directed by a doctor
OTC - STOP USE SECTION
Stop use and ask a doctor if
- the condition persists or gets worse
- if a rash or other allergic reaction develops
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- clean the affected area
- apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
- may be covered with a sterile bandage
Other information
- do not use if seal is punctured or is not visible. To open, reverse cap to puncture seal
- store at room temperature
- see crimp of tube for Lot No. and Exp. date
INACTIVE INGREDIENT SECTION
Inactive ingredient white petrolatum
Questions or comments? call toll free 1-800-645-9833
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 1/2 Oz CONTAINER
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 1/2 Oz CARTON
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 1/32 Oz CONTAINER
NDC 0168-0012-09
Fougera®
First Aid Antibiotic NET WT 0.9 g (1/32 Oz)
Triple Antibiotic Ointment
(Neomycin and Polymyxin B Sulfates
and Bacitracin Zinc Ointment USP)
Uses: First aid to help prevent infection in
• minor cuts • scrapes • burns

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – FOILPAC CARRIER CARTON
NDC 0168-0012-09
Fougera ®
Triple
Antibiotic Ointment
(Neomycin and Polymyxin B Sulfates
and Bacitracin Zinc Ointment USP)
First Aid Antibiotic
This product available in tubes at pharmacy.
1 GROSS
NET WT 0.9 g (1/32 Oz) FOILPACS®

DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0168-0012-09 | EA - Each | 0168-0012 | f955a9b2-cb31-4572-a5ec-c455dd57c71b | 1 | 2012-07-24 |
| 0168-0012-31 | GM - Gram | 0168-0012 | 744c935d-272c-436f-8e28-39a21fb01c43 | 1 | 2012-07-24 |
| 0168-0012-35 | GM - Gram | 0168-0012 | 71a23c05-c781-467e-aca8-9c0a572a5724 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | 2 | |
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | 2 | |
| Polymyxin B Sulfate | ACTIVE INGREDIENT | 19371312D4 | 2 | |
| BACITRACIN | ACTIVE MOIETY | 58H6RWO52I | 2 | |
| NEOMYCIN | ACTIVE MOIETY | I16QD7X297 | 2 | |
| Polymyxin B | ACTIVE MOIETY | J2VZ07J96K | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 |
Products#
Every source-derived product name is available through these pages.
- Triple Antibiotic
- Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
- Bacitracin Zinc
- BACITRACIN
- NEOMYCIN SULFATE
- NEOMYCIN
- Polymyxin B Sulfate
- Polymyxin B
- petrolatum
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0168-0012 | 0168-0012-35, 0168-0012-31, 0168-0012-09 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Bacitracin Zinc | 89Y4M234ES | ACTIB |
| NEOMYCIN SULFATE | 057Y626693 | ACTIM |
| Polymyxin B Sulfate | 19371312D4 | ACTIB |
| petrolatum | 4T6H12BN9U | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 17785628-26c0-4498-aba8-c121fafb36d4 | b60b7ea1-7fda-4417-ac43-eb5129136b95 | 2012-10-22 | Warnings | 17785628-26c0-4498-aba8-c121fafb36d4 b60b7ea1-7fda-4417-ac43-eb5129136b95 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

